Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 10Neoplasm Metastasis 9Carcinoma, Non-Small-Cell Lung 5Recurrence 3Prostatic Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Lung Neoplasms 3Endometrial Neoplasms 3Colorectal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Solid Tumors 2Ovarian Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Head and Neck Neoplasms 2Glioblastoma 2Waldenstrom Macroglobulinemia 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Thyroid Neoplasms 1Thymoma 1Skin Neoplasms 1Salivary Gland Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Non Castrate Metastatic Prostate Cancer 1Neoplasms 1Nasopharyngeal Neoplasms 1

Interventions

Cisplatin 25Cetuximab 12Radiotherapy 11Docetaxel 11Fluorouracil 9Carboplatin 9Surgical Procedures, Operative 8Radiotherapy, Intensity-Modulated 8pembrolizumab 7Magnetic Resonance Spectroscopy 7Radiation 6Surveys and Questionnaires 5Specimen Handling 5Drug Therapy 5toripalimab 4Standard of Care 4Celecoxib 41,2-diaminocyclohexaneplatinum II citrate 4X-Rays 3Platinum 3Paclitaxel 3Nutritional Status 3Interviews as Topic 3Hydroxyurea 3Counseling 3Biopsy 3130-nm albumin-bound paclitaxel 3Taxes 2Resistance Training 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Laryngeal Neoplasms × NVP-BKM120 × Clear all
NCT02113878 2024-11-05

Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck

Dana-Farber Cancer Institute

Phase 1 Completed
23 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡